Katarzyna Kolasa

Predictors of costs of care in Alzheimer's disease: A multinational sample of 1222 patients

Anders Gustavsson, Per Brinck, Niklas Bergvall et al. · Alzheimer s & Dementia · 2011 · 136 citations

Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs

Katarzyna Kolasa, Krzysztof Zwoliński, Zoltán Kaló et al. · Orphanet Journal of Rare Diseases · 2016 · 47 citations · Full text

Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis

Katarzyna Kolasa, Krzysztof Zwoliński, V. Zah et al. · Orphanet Journal of Rare Diseases · 2018 · 35 citations · Full text

Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries

Katarzyna Kolasa, Zoltán Kaló, Vladimir Zah et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2012 · 33 citations

Relevant Experience, Engineering, Eu Transparency Directive +23

The Cost-Effectiveness of Saxagliptin Versus NPH Insulin When Used in Combination with Other Oral Antidiabetes Agents in the Treatment of Type 2 Diabetes Mellitus in Poland

W Grzeszczak, Leszek Czupryniak, Katarzyna Kolasa et al. · Diabetes Technology & Therapeutics · 2011 · 22 citations